ADPT - Company ID 0001478320
The table below shows Adaptive Biotechnologies Corp's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $70.50M | $47.92M | $65.06M | $90.03M | $139.06M | $123.44M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $50.37M | $41.73M | $37.97M | $40.06M | $17.41M | $10.05M |
| Inventory | $9.82M | $8.44M | $14.45M | $14.45M | $19.26M | $14.06M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $300.19M |
| $283.75M |
| $410.19M |
| $562.15M |
| $402.75M |
| $726.91M |
| Property, plant & equipment | $34.11M | $48.62M | $68.23M | $83.45M | $85.26M | $39.69M |
| Goodwill | $118.97M | $118.97M | $118.97M | $118.97M | $118.97M | $118.97M |
| Total assets | $512.74M | $539.38M | $661.13M | $856.62M | $923.34M | $1.12B |
| Accounts payable | $6.47M | $7.26M | $7.72M | $8.08M | $3.31M | $3.24M |
| Total current liabilities | $89.92M | $98.05M | $88.02M | $109.79M | $113.81M | $105.20M |
| Long-term debt | $126.57M | $132.41M | $130.66M | - | - | - |
| Total liabilities | $287.74M | $336.89M | $352.86M | $392.52M | $319.24M | $373.15M |
| Retained earnings | -$1.36B | -$1.30B | -$1.14B | -$919.08M | -$718.89M | -$511.61M |
| Total equity | $218.79M | $202.71M | $308.40M | $464.17M | $603.99M | $743.27M |